Contact
| Email: | |
|---|---|
| Phone: | +420 54949 5875 |
| Research group: | Functional Genomics - Michal Šmída, Medical Genomics - Šárka Pospíšilová |
| Workplace: |
24. Apr. 2020
Researchers From CEITEC Described Biomarkers That Predict Response to CAR-T Cell Cancer Therapy
Veronika Mancikova and other members of the Michal Smida Research Group from CEITEC Masaryk University, in collaboration with their colleagues from…
18. Dec. 2019
Doktorandka Aneta Ledererová z institutu CEITEC získala Pamětní grant Martiny Roeselové, který jí pomůže skloubit vědeckou kariéru s mateřstvím
Tisková zpráva, 16. prosince 2019; Doktorandka Aneta Ledererová z výzkumné skupiny Michala Šmídy získala Pamětní grant Martiny Roeselové.…
Publications that are part of the Web of Science database, possibly also other publications chosen by authors.
2020
- Mancikova, V; Peschelova, H; Kozlova, V; Ledererova, A; Ladungova, A; Verner, J; Loja, T; Folber, F; Mayer, J; Pospisilova, S; Smida, M, 2020: Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia. JOURNAL FOR IMMUNOTHERAPY OF CANCER 8(1), doi: 10.1136/jitc-2019-000471
- Kozlova, V; Ledererova, A; Ladungova, A; Peschelova, H; Janovska, P; Slusarczyk, A; Domagala, J; Kopcil, P; Vakulova, V; Oppelt, J; Bryja, V; Doubek, M; Mayer, J; Pospisilova, S; Smida, M, 2020: CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells. PLOS ONE 15(3), doi: 10.1371/journal.pone.0229170
2017
- Ledererova, A; Kozlova, V; Vakulova, V; Doubek, M; Mayer, J; Pospisilova, S; Smida, M, 2017: B CELLS RESISTANT TO CD20 MONOCLONAL ANTIBODIES DISPLAY SPECIFIC ALTERATIONS IN GENE EXPRESSION PROFILE. HAEMATOLOGICA 102, p. 709 - 709
2016
- Smida, M; Kozlova, V; Vakulova, V; Ledererova, A; Doubek, M; Mayer, J; Pospisilova, S, 2016: Cellular Mechanisms Regulating CD20 As a Target of Monoclonal Antibody Therapy in B-Lymphoid Malignancies. BLOOD 128(22)
- Expression and function of activation-induced cytidine deaminase splice variants in normal B cell physiology and chronic lymphocytic leukemia (3SGA5792), Jihomoravský kraj, 2013 - 2016
- Functional and structural changes of microRNAs in lymphoproliferative malignancies and their impact on prognosis and prediction of therapy response (NT11218), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2015
- NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (306242), Evropská unie, 2012 - 2015
- SuPReMMe - Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny (CZ.1.07/2.3.00/20.0045), Ministerstvo školství, mládeže a tělovýchovy ČR, 2011 - 2014
- Real-time PCR soupravy pro diagnostiku v onkologii (FR-TI2/254), Ministerstvo průmyslu a obchodu ČR, 2010 - 2013
- Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies (MSM0021622430), Ministerstvo školství, mládeže a tělovýchovy ČR, 2007 - 2013
- Involvement of nuclear HMGB proteins in sensitizing of human cells to anticancer drugs inhibiting DNA topoizomerases (GAP301/10/0590), Czech Science Foundation - Standard Grants, 2010 - 2012
- Analysis of changes in genome and its expression in chronic lymphocytic leukemia patients during the disease development (NS10439), Ministry of Health - Departmental Programme of Research and Development (2008-2011), 2009 - 2011